R. Oberhoffer et al., CARDIAC AND EXTRACARDIAC COMPLICATIONS IN INFANTS OF DIABETIC MOTHERSAND THEIR RELATION TO PARAMETERS OF CARBOHYDRATE-METABOLISM, European journal of pediatrics, 156(4), 1997, pp. 262-265
Despite the current improvement of diabetes care in pregnancy, neonata
l complications are still more frequent than in the general population
. Even in fetuses of well controlled diabetic mothers, myocardial hype
rtrophy can be demonstrated although it is not related to maternal met
abolic control. The objective of this study was to determine perinatal
complications and the course of myocardial hypertrophy in newborns wh
o had been prenatally monitored and to relate the findings to neonatal
parameters of carbohydrate metabolism. Perinatal complications and ec
hocardiographic evidence of myocardial hypertrophy were determined in
104 neonates of closely followed diabetic mothers. Cord blood was obta
ined for determination of insulin, C-peptide and glycosylated fetal ha
emoglobin (HbF(1c)). In cases of myocardial hypertrophy, the echocardi
ographic examinations were repeated until normalisation of the myocard
ial wall thickness. The most striking finding was myocardial hypertrop
hy in 25% of the 104 neonates, which predominantly involved the interv
entricular septum. This is in contrast to the prenatal symmetrical hyp
ertrophy of the ventricular walls and may be explained by perinatal ch
angings of ventricular geometry. There was no sign of outflow tract ob
struction, and myocardial hypertrophy resolved within 6 months. Insuli
n and C-peptide were elevated in the majority of the newborns, whereas
HbF(1c) was significantly decreased. Neither the maternal type of dia
betes nor neonatal metabolic data were related to the somatic findings
. Conclusion Myocardial hypertrophy still occurs in infants of diabeti
c mothers despite their good metabolic control reflected by the decrea
sed fraction of glycosylated fetal hemoglobin which points to low feta
l blood sugar levels during the last intra-uterine weeks.